A detailed history of Bryn Mawr Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bryn Mawr Trust CO holds 79,245 shares of BDX stock, worth $18.3 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
79,245
Previous 76,011 4.25%
Holding current value
$18.3 Million
Previous $19.7 Million 0.21%
% of portfolio
0.77%
Previous 0.89%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $754,977 - $801,158
3,234 Added 4.25%
79,245 $19.6 Million
Q3 2023

Nov 15, 2023

SELL
$254.9 - $283.59 $170,783 - $190,005
-670 Reduced 0.87%
76,011 $19.7 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $586,439 - $652,687
-2,460 Reduced 3.11%
76,681 $20.2 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $444,488 - $501,842
-1,935 Reduced 2.39%
79,141 $19.6 Million
Q4 2022

Feb 10, 2023

SELL
$218.29 - $256.91 $38,200 - $44,959
-175 Reduced 0.22%
81,076 $20.6 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $37,864 - $196,058
-742 Reduced 0.9%
81,251 $18.1 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $507,273 - $595,182
-2,161 Reduced 2.57%
81,993 $20.2 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $2.39 Million - $2.65 Million
-9,807 Reduced 10.44%
84,154 $22.4 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $160,595 - $175,156
-698 Reduced 0.74%
93,961 $23.6 Million
Q3 2021

Oct 26, 2021

SELL
$232.72 - $256.47 $277,402 - $305,712
-1,192 Reduced 1.24%
94,659 $23.3 Million
Q2 2021

Jul 29, 2021

SELL
$232.65 - $254.58 $4.8 Million - $5.25 Million
-20,639 Reduced 17.72%
95,851 $23.3 Million
Q1 2021

Apr 23, 2021

SELL
$232.09 - $256.88 $488,781 - $540,989
-2,106 Reduced 1.78%
116,490 $28.3 Million
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $320,674 - $355,383
-1,445 Reduced 1.2%
118,596 $29.7 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $425,929 - $546,324
1,974 Added 1.67%
120,041 $27.9 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $3.14 Million - $3.76 Million
-14,292 Reduced 10.8%
118,067 $28.3 Million
Q1 2020

May 08, 2020

BUY
$195.69 - $279.01 $395,098 - $563,321
2,019 Added 1.55%
132,359 $30.4 Million
Q4 2019

Feb 11, 2020

BUY
$236.45 - $266.82 $388,960 - $438,918
1,645 Added 1.28%
130,340 $35.4 Million
Q3 2019

Oct 24, 2019

SELL
$230.58 - $256.08 $26,516 - $29,449
-115 Reduced 0.09%
128,695 $32.6 Million
Q2 2019

Aug 15, 2019

SELL
$217.4 - $246.08 $2.74 Million - $3.11 Million
-12,624 Reduced 8.93%
128,810 $32.5 Million
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $675,431 - $813,501
3,278 Added 2.37%
141,434 $35.3 Million
Q4 2018

Feb 15, 2019

BUY
$204.73 - $257.93 $86,600 - $109,104
423 Added 0.31%
138,156 $31.1 Million
Q3 2018

Nov 15, 2018

SELL
$233.07 - $256.0 $192,515 - $211,456
-826 Reduced 0.6%
137,733 $35.9 Million
Q2 2018

Aug 28, 2019

SELL
$208.1 - $233.85 $1.23 Million - $1.38 Million
-5,920 Reduced 4.1%
138,559 $33.2 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $263,870 - $296,521
-1,268 Reduced 0.87%
144,479 $34.6 Million
Q1 2018

Aug 28, 2019

SELL
$205.46 - $240.27 $24,655 - $28,832
-120 Reduced 0.08%
145,747 $31.6 Million
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $2.27 Million - $2.66 Million
-11,058 Reduced 7.05%
145,867 $31.6 Million
Q4 2017

Aug 28, 2019

SELL
$189.0 - $222.64 $1,701 - $2,003
-9 Reduced 0.01%
156,925 $33.6 Million
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $1.92 Million - $2.26 Million
10,144 Added 6.91%
156,934 $33.6 Million
Q3 2017

Aug 28, 2019

SELL
$186.89 - $198.9 $8,410 - $8,950
-45 Reduced 0.03%
146,790 $28.8 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $27.4 Million - $29.2 Million
146,835
146,835 $28.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.